Viewing StudyNCT05549661

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 6:06 PM
Last Modification Date: 2024-10-26 @ 2:41 PM
Study NCT ID: NCT05549661
Status: RECRUITING
Last Update Posted: 2024-06-21
First Post: 2022-09-19
Brief Title: Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia
Sponsor: Mayo Clinic
Organization: Mayo Clinic
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Recurrent Chronic Myelomonocytic Leukemia
Refractory Chronic Myelomonocytic Leukemia
Keywords: